eMedicine Specialties > Pediatrics: General Medicine > Nephrology
Medullary Sponge Kidney
Updated: Dec 11, 2007
Introduction
Background
Medullary sponge kidney (MSK) is likely the result of an abnormality in renal development, as evidenced by the occasional presence of embryonal tissue in the affected papillae. Recent findings suggest that MSK may result from disruption of the ureteric bud/metanephric-blastema interface that is critical in normal kidney development.1
MSK is characterized by ectasia and cystic formation in the medullary collecting duct. This characterization contrasts with autosomal recessive polycystic kidney disease and with autosomal dominant polycystic kidney disease, in which cysts predominantly develop along the cortical collecting tubule or the entire nephron, respectively. Medullary cysts give the kidney the gross anatomic appearance of a sponge. In the absence of hematuria, renal calculi, or infection, the disease is an asymptomatic nonprogressive condition.
Pathophysiology
The kidney is the primary organ affected. Ectasia and cystic malformation are present along the intrapyramidal or intrapapillary portion of the medullary collecting duct. Cysts may be heterogeneous in size within one kidney and between the 2 kidneys, ranging in size from 1-3 mm. Cysts may communicate and often contain spherical concretions composed of apatite.
Although the cause of medullary sponge kidney is unknown, family occurrence suggests a genetic component. Pathological studies suggest that medullary sponge kidney is due to an obstruction of the fetal-collecting duct or to a structural defect caused by hypercalciuria. The presence of embryonal remnant tissue in some cases links the condition to a congenital developmental defect in this nephron segment.
Medullary sponge kidney may be part of other syndromes and conditions such as Beckwith-Wiedemann syndrome (BWS), hemihypertrophy, Caroli disease, Ehlers-Danlos syndrome, Marfan syndrome, and pyloric stenosis. Medullary sponge kidney may occur in up to 12.5% of cases of BWS, if congenital hemihypertrophy is part of the clinical picture.
Frequency
United States
The prevalence rate is 1 case per 5,000-20,000 population. MSK may be detected in 0.5-1% of asymptomatic individuals who undergo renal imaging studies for assorted clinical indications.
International
Evidence indicates that worldwide incidence of MSK is similar to that found in the United States.
Mortality/Morbidity
Morbidity or mortality is not directly related to MSK. In the absence of hematuria, urinary tract infection (UTI), or renal calculi, MSK is usually a nonprogressive asymptomatic condition.
- Under normal conditions, patients may have a mild urinary-concentrating defect or low-grade proteinuria.
- Patients have a higher risk for developing calcium oxalate/apatite or struvite renal calculi. Factors that may contribute to the susceptibility to recurrent calcium urolithiasis include: (1) urine stasis, (2) incomplete renal tubular acidosis (RTA) with a mild defect in urinary acidification and increased urine pH levels, (3) hypocitric aciduria, and (4) hypercalciuria. Patients are usually aged 20-50 years at presentation, although the condition may occur in children younger than 5 years. As many as 20% of adults with kidney stones may have MSK; the corresponding figure in children is unknown. Among patients with kidney stones, hypercalciuria may occur in 40-50%, and recurrent gross hematuria may occur in 10-20%.
- Hyperparathyroidism is frequently associated with MSK and was thought to cause the disease and trigger stone formation. However, the urinary findings and clinical features of MSK usually precede the detection of hyperparathyroidism.
- Although no evidence indicates that risk of UTIs is higher in patients with medullary sponge kidney, as many as 5% of males and 35% of females have a UTI. These patients do not have an increased frequency of concomitant structural anomalies (eg, vesicoureteral reflux) to account for the occurrence of UTI.
Race
No epidemiologic data indicate that incidence varies among racial or ethnic subgroups.
Sex
No evidence indicates that the frequency differs between the sexes. Fewer than 5% of cases are familial, and a clear genetic basis for MSK has not been established. The only genetic pattern observed in select pedigrees is an autosomal dominant type of transmission. MSK appears to be somewhat more severe in women; the incidence of renal calculi and UTIs in women is higher than in men.
Age
Symptoms occur primarily in adults aged 20-50 years; however, infants as young as 2 years and adolescents have shown clinical symptoms.
Clinical
History
- Patients are usually asymptomatic.
- Patients may develop microhematuria or signs and symptoms of gross hematuria, renal stone development, or UTI.
Physical
- Although physical examination findings are usually normal, as many as 25% of patients have hemihypertrophy, and 10% of patients with hemihypertrophy may have medullary sponge kidney, although no explanation for this association exists. Children with medullary sponge kidney (MSK) and hemihypertrophy may have an incomplete form of BWS. Moreover, because of the high risk of malignancies in patients with BWS, these patients should be screened periodically for malignancies, including abdominal tumors.
- Urinalysis findings may show hematuria, low-grade proteinuria, and mild acidification and concentrating defects.
Causes
The cause of MSK is unknown.
- No cases link MSK to a drug or environmental exposure.
- Cases occasionally occur in a familial pattern consistent with autosomal dominant transmission. In these circumstances, MSK may be associated with unilateral renal agenesis or other renal or genitourinary tract abnormalities.
More on Medullary Sponge Kidney |
Overview: Medullary Sponge Kidney |
| Differential Diagnoses & Workup: Medullary Sponge Kidney |
| Treatment & Medication: Medullary Sponge Kidney |
| Follow-up: Medullary Sponge Kidney |
| References |
| Next Page » |
References
Gambaro G, Feltrin GP, Lupo A, et al. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int. Feb 2006;69(4):663-70. [Medline].
Abeshouse BS, Abeshouse GA. Sponge kidney: a review of the litrature and a report of five cases. J Urol. Aug 1960;84:252-67. [Medline].
Avner ED. Medullary sponge kidney. In: Greenber A, Cheung AK, Coffman TM, et al, eds. NKF Primer on Kidney Disease. 1997.
Osther PJ, Mathiasen H, Hansen AB, et al. Urinary acidification and urinary excretion of calcium and citrate in women with bilateral medullary sponge kidney. Urol Int. 1994;52(3):126-30. [Medline].
Patriquin HB, O'Regan S. Medullary sponge kidney in childhood. AJR Am J Roentgenol. Aug 1985;145(2):315-9. [Medline].
Further Reading
Keywords
MSK, medullary sponge kidney, medullary cysts, renal cyst, Beckwith-Wiedemann syndrome, BWS, hemihypertrophy, Caroli disease, Ehlers-Danlos syndrome, Marfan syndrome, Marfan's syndrome, pyloric stenosis, kidney stones, renal stones, ectasia, hypercalciuria, urinary tract infection, UTI, hypocitric aciduria, hypercalciuric urolithiasis, autosomal recessive polycystic kidney disease, ARPKD, hematuria, renal calculi, recurrent calcium urolithiasis, renal tubular acidosis, RTA, hyperparathyroidism, gross hematuria
Overview: Medullary Sponge Kidney